CEO presentation posted for TechKnow Invest Roadshow
Immuron published a CEO presentation for the TechKnow Invest Roadshow held today at Sofitel Melbourne on Collins.
Presentation highlights Travelan (IMM-124E), an oral hyperimmune bovine antibody product positioned to reduce travelers’ diarrhea risk; sold as a dietary supplement in the U.S.
Slides also cover IMM-529 for recurrent C. difficile, citing preclinical results showing 80% primary prevention, 67% recurrence protection, 78.6% treatment.
Materials include ProIBS distribution in Australia and New Zealand, positioned for IBS symptom relief as a certified medical device.
IMRN•
